The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo

Z Y Yang1, N D Perkins, T Ohno

  • 1Howard Hughes Medical Institute, University of Michigan Medical Center, Department of Internal Medicine, Ann Arbor 48109-0650, USA.

Nature Medicine
|October 1, 1995
PubMed

Insights

The p21 gene inhibits malignant cell growth and causes differentiation, not apoptosis. Gene transfer of p21 offers a novel approach to halt cancer progression by inducing terminal cell differentiation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The p21 gene encodes a cyclin-dependent kinase inhibitor.
  • Its role as a tumor suppressor in vivo remains unestablished.
  • p21 influences cell-cycle progression.

Purpose of the Study:

  • To investigate the in vivo tumor suppressor potential of the p21 gene.
  • To determine the effects of p21 expression on malignant cell growth and differentiation.

Main Methods:

  • Expression of p21 in malignant cells in vitro and in vivo.
  • Utilized adenoviral vectors for gene transfer of p21.
  • Monitored cell-cycle progression, morphology, differentiation, and apoptosis.

Main Results:

  • p21 expression inhibited malignant cell growth both in vitro and in vivo.
  • Accumulation of cells in the G0/G1 phase was observed.
  • Altered cell morphology and induced cell differentiation occurred, but apoptosis was not triggered.
  • Adenoviral delivery of p21 suppressed existing tumor growth.

Conclusions:

  • p21 functions as a tumor suppressor in vivo.
  • Gene transfer of p21 represents a potential molecular genetic strategy for cancer therapy.
  • p21 may irreversibly commit malignant cells to terminal differentiation, arresting cancer growth.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...